Skip to content

the effect of Tiaoshen Acupuncture for cancer fatigue in breast cancer survivors based on metabolomics analysis

the effect of Tiaoshen Acupuncture for cancer fatigue in breast cancer survivors based on metabolomics analysis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002874
Enrollment
Unknown
Registered
2019-12-27
Start date
2020-01-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Related Fatigue

Interventions

Sponsors

Traditional Chinese Medical Hospital of Huzhou,Affiliated to Traditional Chinese Medical University of Zhejiang
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for breast cancer survivors and cancer fatigue; 2. Within 3-6 months after surgery for breast cancer, and not during chemotherapy; 3. Aged 18-75 years; 4. Karnofsky functional status rating scale (KPS) score is greater than or equal to 60; 5. Agree to participate in this study, understand and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Breast cancer IV level; 2. And take any hypnotic sedatives or psychoactive substances within 24 hours; 3. Combined with other cancers or more serious heart, liver, kidney and other chronic diseases; 4. Patients with mental disorders or severe cognitive impairment who cannot participate in cooperation; 5. Other physiological or pathological fatigue such as chronic fatigue syndrome; 6. Patients who had received acupuncture in the past 6 months; 7. Pregnant or nursing women.

Design outcomes

Primary

MeasureTime frame
Metabolomics - related serum metabolic markers;

Secondary

MeasureTime frame
MFI-20;Karnofsky scale;Pittsburgh Sleep Quality Index;Qi-deficiency related syndromes of TCM;Hamilton Depression Scale;

Countries

China

Contacts

Public ContactLI Jinxia
lijinxia310@163.com+86 13857299145

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026